Objectives: 5−10% of CF patients are diagnosed as adults. They often present with non-classical CF and suffer a milder clinical course. We postulate an increased incidence of adult CF diagnoses. We sought to determine if the adult CF, diagnostic characteristics and clinical course differed between 2000-2009 and 1990-1999. Methods: Patients attending CF centres in Northern Ireland from 1990 with a diagnosis of CF after the age of 16 were identified. Comparison of their demographics and biostatistics was made and a F508del homozygous cohort used as a control. Results: Fifty-two patients were identified. There was an increased incidence of individuals diagnosed with CF in adulthood in the latter decade (12 vs 40). Mean age at diagnosis was 30.4(±4.0) yrs in the 90's and 43.2(±2.7) yrs in the 00's (p = 0.02). The majority of patients presented with respiratory manifestations in both cohorts. Mean FEV 1 % predicted at presentation in the 90's group 71.3% (±7.6) and the 00's group 76.9% (±4.1) (p = 0.52). Class 1−3 mutations represented 75% of the 90's group and 50% of the 00's (p = 0.18), Class 4 mutations 25% of 90's and 2.5% of 00's (p = 0.03) and unknown mutations accounted for 0% of 90's and 50% of 00's (p = 0.002). A comparison of FEV 1 % decline between the late diagnosis group (0.46 ml/yr) and F508del homozygous patients (1.64 ml/yr) (p = 0.02). Conclusions: Owing to the increased recognition of the heterogeneity of CF, this diagnosis is increasingly being made in adulthood. The majority of patients in both cohorts presented with Bronchiectasis. While having a milder clinical course these patients still suffer a considerable burden of disease and have a declining respiratory status. Newborn screening (NBS) allows a better appreciation of CF birth incidence that appears lower than in the past. Here we reported time trends in incidence of CF over a long period (40 years: 1970-2009) in an area where CF is frequent (Brittany, France) and where NBS is implemented since a long time (1989). The study enrolled the CF patients born in Brittany since 1970. The cases born before the set up of NBS were registered through active enquiries and combination of data sources. Time trends in incidence rates were examined using Poisson regression and expressed by the average percent change (APC) with its 95% confidence interval (95% CI). The APC was derived from the formula ([exp(beta) − 1]·100), beta representing the effect of time on the logarithm of the incidence rate. Over the 40-year period, 569 CF children born in Brittany were registered, leading to a CF incidence rate of 1/2617. The mean number of cases born each year varied from 17.7 in the 1970's (decade 1970−79) to 11.8 nowadays (decade 2000−09). This corresponded to a decline in incidence rate of 29.0% (from 1/2260 to 1/3183). Poisson regression showed that the incidence rate decreased over the whole period 
371* Evidence of decline in cystic fibrosis (CF) incidence: study over a 40-year period Newborn screening (NBS) allows a better appreciation of CF birth incidence that appears lower than in the past. Here we reported time trends in incidence of CF over a long period (40 years: 1970-2009 ) in an area where CF is frequent (Brittany, France) and where NBS is implemented since a long time (1989) . The study enrolled the CF patients born in Brittany since 1970. The cases born before the set up of NBS were registered through active enquiries and combination of data sources. Time trends in incidence rates were examined using Poisson regression and expressed by the average percent change (APC) with its 95% confidence interval (95% CI). The APC was derived from the formula ([exp(beta) − 1]·100), beta representing the effect of time on the logarithm of the incidence rate. Over the 40-year period, 569 CF children born in Brittany were registered, leading to a CF p.F508del is the most common mutation in cystic fibrosis (CF). The aim of this study was to determine the prevalence of p.F508del and its relation to clinical manifestations in CF.
Methods: This is a single-CF unit retrospective study analyzing the genetic and clinical characteristics of 108 genotyped children from Northern Greece. Mutations were categorized as severe (p.F508del, c.1571delG, p.W1282X, p.G542X, c.1677delTA, p.N1303K, p.E822X, p.R553X, p.R334W, c.621+1G>T, Del exon 2−3(21kb), c.2183AA>G, c.1525 −1G>A, p.G85E, p.D110H, R1158X, 1717 
